{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:23:52Z","timestamp":1791113032471,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T00:00:00Z","timestamp":1257465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s11064-009-0086-6","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T08:37:14Z","timestamp":1257410234000},"page":"495-502","source":"Crossref","is-referenced-by-count":32,"title":["Intrastriatal Transplantation of GDNF-engineered BMSCs and its neuroprotection in Lactacystin-induced Parkinsonian Rat Model"],"prefix":"10.1007","volume":"35","author":[{"given":"Jianjun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,6]]},"reference":[{"issue":"2","key":"86_CR1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ana.20935","volume":"60","author":"JH Kordower","year":"2006","unstructured":"Kordower JH, Kanaan NM, Chu Y et al (2006) Failure of proteasome inhibitor administration to provide a model of Parkinson\u2019s disease in rats and monkeys. Ann Neurol 60(2):264\u2013268","journal-title":"Ann Neurol"},{"issue":"2","key":"86_CR2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.20938","volume":"60","author":"AB Manning-Bog","year":"2006","unstructured":"Manning-Bog AB, Reaney SH, Chou VP et al (2006) Lack of nigrostriatal pathology in a rat model of proteasome inhibition. Ann Neurol 60(2):256\u2013260","journal-title":"Ann Neurol"},{"issue":"2","key":"86_CR3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.20936","volume":"60","author":"KS McNaught","year":"2006","unstructured":"McNaught KS, Olanow CW (2006) Proteasome inhibitor-induced model of Parkinson\u2019s disease. Ann Neurol 60(2):243\u2013247","journal-title":"Ann Neurol"},{"issue":"1","key":"86_CR4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","volume":"56","author":"KS McNaught","year":"2004","unstructured":"McNaught KS, Perl DP, Brownell AL et al (2004) Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson\u2019s disease. Ann Neurol 56(1):149\u2013162","journal-title":"Ann Neurol"},{"issue":"2","key":"86_CR5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.20932","volume":"60","author":"BY Zeng","year":"2006","unstructured":"Zeng BY, Bukhatwa S, Hikima A et al (2006) Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats. Ann Neurol 60(2):248\u2013252","journal-title":"Ann Neurol"},{"issue":"11 Suppl","key":"86_CR6","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0166-2236(00)01998-6","volume":"24","author":"KK Chung","year":"2001","unstructured":"Chung KK, Dawson VL, Dawson TM (2001) The role of the ubiquitin-proteasomal pathway in Parkinson\u2019s disease and other neurodegenerative disorders. Trends Neurosci 24(11 Suppl):S7\u2013S14","journal-title":"Trends Neurosci"},{"issue":"1","key":"86_CR7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainres.2006.01.083","volume":"1082","author":"GP Dietz","year":"2006","unstructured":"Dietz GP, Valbuena PC, Dietz B et al (2006) Application of a blood-brain-barrier-penetrating form of GDNF in a mouse model for Parkinson\u2019s disease. Brain Res 1082(1):61\u201366","journal-title":"Brain Res"},{"issue":"3","key":"86_CR8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neulet.2006.11.017","volume":"412","author":"MP Smith","year":"2007","unstructured":"Smith MP, Cass WA (2007) GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson\u2019s disease. Neurosci Lett 412(3):259\u2013263","journal-title":"Neurosci Lett"},{"issue":"2","key":"86_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12264-007-0010-5","volume":"23","author":"YR Su","year":"2007","unstructured":"Su YR, Wang J, Wu JJ et al (2007) Overexpression of lentivirus-mediated glial cell line-derived neurotrophic factor in bone marrow stromal cells and its neuroprotection for the PC12 cells damaged by lactacystin. Neurosci Bull 23(2):67\u201374","journal-title":"Neurosci Bull"},{"issue":"3","key":"86_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12264-007-0020-3","volume":"23","author":"HL Zhang","year":"2007","unstructured":"Zhang HL, Wu JJ, Ren HM et al (2007) Therapeutic effect of microencapsulated porcine retinal pigmented epithelial cells transplantation on rat model of Parkinson\u2019s disease. Neurosci Bull 23(3):137\u2013144","journal-title":"Neurosci Bull"},{"issue":"1","key":"86_CR11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","volume":"179","author":"KS McNaught","year":"2003","unstructured":"McNaught KS, Belizaire R, Isacson O et al (2003) Altered proteasomal function in sporadic Parkinson\u2019s disease. Exp Neurol 179(1):38\u201346","journal-title":"Exp Neurol"},{"issue":"45","key":"86_CR12","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","volume":"278","author":"GK Tofaris","year":"2003","unstructured":"Tofaris GK, Razzaq A, Ghetti B et al (2003) Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem 278(45):44405\u201344411","journal-title":"J Biol Chem"},{"issue":"2","key":"86_CR13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","volume":"58","author":"JE Galvin","year":"2001","unstructured":"Galvin JE, Lee VM, Trojanowski JQ (2001) Synucleinopathies: clinical and pathological implications. Arch Neurol 58(2):186\u2013190","journal-title":"Arch Neurol"},{"issue":"6645","key":"86_CR14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM et al (1997) Alpha-synuclein in Lewy bodies. Nature 388(6645):839\u2013840","journal-title":"Nature"},{"issue":"5321","key":"86_CR15","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"2","key":"86_CR16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-4159.2002.00821.x","volume":"81","author":"KS McNaught","year":"2002","unstructured":"McNaught KS, Mytilineou C, Jnobaptiste R et al (2002) Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem 81(2):301\u2013306","journal-title":"J Neurochem"},{"issue":"5","key":"86_CR17","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1471-4159.2005.03124.x","volume":"93","author":"H Rideout","year":"2005","unstructured":"Rideout H, Lang-Rollin I, Savalle M et al (2005) Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition. J Neurochem 93(5):1304\u20131313","journal-title":"J Neurochem"},{"issue":"2","key":"86_CR18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exnr.2002.7891","volume":"175","author":"R Deumens","year":"2002","unstructured":"Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson\u2019s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175(2):303\u2013317","journal-title":"Exp Neurol"},{"key":"86_CR19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.brainres.2008.05.022","volume":"1222","author":"T Pan","year":"2008","unstructured":"Pan T, Zhu W, Zhao H et al (2008) Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo. Brain Res 1222:222\u2013229","journal-title":"Brain Res"},{"issue":"4","key":"86_CR20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pneurobio.2008.05.001","volume":"85","author":"T Deierborg","year":"2008","unstructured":"Deierborg T, Soulet D, Roybon L et al (2008) Emerging restorative treatments for Parkinson\u2019s disease. Prog Neurobiol 85(4):407\u2013432","journal-title":"Prog Neurobiol"},{"issue":"6571","key":"86_CR21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/380252a0","volume":"380","author":"DM Gash","year":"1996","unstructured":"Gash DM, Zhang Z, Ovadia A et al (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380(6571):252\u2013255","journal-title":"Nature"},{"issue":"6","key":"86_CR22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2176\/nmc.46.267","volume":"46","author":"Y Oiwa","year":"2006","unstructured":"Oiwa Y, Nakai K, Itakura T (2006) Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys. Neurol Med Chir (Tokyo) 46(6):267\u2013275 discussion 275\u2013266","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"2","key":"86_CR23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nn1175","volume":"7","author":"D Kirik","year":"2004","unstructured":"Kirik D, Georgievska B, Bjorklund A (2004) Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat Neurosci 7(2):105\u2013110","journal-title":"Nat Neurosci"},{"issue":"1","key":"86_CR24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-2999(00)00933-X","volume":"412","author":"S Costa","year":"2001","unstructured":"Costa S, Iravani MM, Pearce RK et al (2001) Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets. Eur J Pharmacol 412(1):45\u201350","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"86_CR25","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1523\/JNEUROSCI.20-12-04686.2000","volume":"20","author":"D Kirik","year":"2000","unstructured":"Kirik D, Rosenblad C, Bjorklund A et al (2000) Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson\u2019s model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci 20(12):4686\u20134700","journal-title":"J Neurosci"},{"issue":"2","key":"86_CR26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nbd.2004.06.008","volume":"17","author":"C Lo Bianco","year":"2004","unstructured":"Lo Bianco C, Deglon N, Pralong W et al (2004) Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson\u2019s disease. Neurobiol Dis 17(2):283\u2013289","journal-title":"Neurobiol Dis"},{"issue":"12","key":"86_CR27","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1172\/JCI200420935","volume":"113","author":"M Dezawa","year":"2004","unstructured":"Dezawa M, Kanno H, Hoshino M et al (2004) Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113(12):1701\u20131710","journal-title":"J Clin Invest"},{"issue":"5","key":"86_CR28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA et al (2008) Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med 14(5):504\u2013506","journal-title":"Nat Med"},{"issue":"4","key":"86_CR29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/157015905774322507","volume":"3","author":"M Dezawa","year":"2005","unstructured":"Dezawa M, Ishikawa H, Hoshino M et al (2005) Potential of bone marrow stromal cells in applications for neuro-degenerative, neuro-traumatic and muscle degenerative diseases. Curr Neuropharmacol 3(4):257\u2013266","journal-title":"Curr Neuropharmacol"},{"issue":"Pt 7","key":"86_CR30","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/brain\/awh510","volume":"128","author":"I Mendez","year":"2005","unstructured":"Mendez I, Sanchez-Pernaute R, Cooper O et al (2005) Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson\u2019s disease. Brain 128(Pt 7):1498\u20131510","journal-title":"Brain"},{"issue":"2","key":"86_CR31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tins.2004.12.006","volume":"28","author":"C Winkler","year":"2005","unstructured":"Winkler C, Kirik D, Bjorklund A (2005) Cell transplantation in Parkinson\u2019s disease: how can we make it work? Trends Neurosci 28(2):86\u201392","journal-title":"Trends Neurosci"},{"issue":"1\u20132","key":"86_CR32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12031-008-9166-3","volume":"39","author":"M Bahat-Stroomza","year":"2009","unstructured":"Bahat-Stroomza M, Barhum Y, Levy YS et al (2009) Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson\u2019s disease. J Mol Neurosci 39(1\u20132):199\u2013210","journal-title":"J Mol Neurosci"},{"issue":"1","key":"86_CR33","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.expneurol.2006.12.004","volume":"204","author":"CJ Chen","year":"2007","unstructured":"Chen CJ, Ou YC, Liao SL et al (2007) Transplantation of bone marrow stromal cells for peripheral nerve repair. Exp Neurol 204(1):443\u2013453","journal-title":"Exp Neurol"},{"issue":"3","key":"86_CR34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bbrc.2004.02.111","volume":"316","author":"R Garcia","year":"2004","unstructured":"Garcia R, Aguiar J, Alberti E et al (2004) Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochem Biophys Res Commun 316(3):753\u2013754","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"86_CR35","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1158\/0008-5472.CAN-04-4194","volume":"65","author":"D Rubio","year":"2005","unstructured":"Rubio D, Garcia-Castro J, Martin MC et al (2005) Spontaneous human adult stem cell transformation. Cancer Res 65(8):3035\u20133039","journal-title":"Cancer Res"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-009-0086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-009-0086-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-009-0086-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T04:36:10Z","timestamp":1559363770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-009-0086-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1007\/s11064-009-0086-6","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,6]]}}}